CVS vs LIN · P/E 16, rev $402.07B vs P/E 34, rev $33.99B
CVS Health Corp (CVS) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the CVS and LIN stock pages for the full models.
Not investment advice.